ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,220Medicare Part D Prescriptions Filled, Including Refills

Rank: 84 out of 324

$520K Total Retail Price of All Prescriptions

Rank: 98 out of 324

340 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
19% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 340 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

17% of this provider’s 340 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

0% of this provider’s 9,787 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
LISINOPRIL 461 434 1 3
SIMVASTATIN 340 315 2 1
FUROSEMIDE 335 329 3 7
HYDROCODONE-ACETAMINOPHEN 335 297 S3 3 5
WARFARIN SODIUM 333 330 5 10
LEVOTHYROXINE SODIUM 323 317 6 2
PRAVASTATIN SODIUM 316 297 7 21
AMLODIPINE BESYLATE 282 282 8 4
METOPROLOL SUCCINATE 268 266 9 17
OMEPRAZOLE 253 239 10 6
ATENOLOL 227 221 11 18
METOPROLOL TARTRATE 207 207 12 14
CITALOPRAM HBR 200 198 13 16
TRIAMTERENE-HCTZ 187 165 14 46
POTASSIUM CHLORIDE 186 184 15 8
ALENDRONATE SODIUM 160 155 16 24
GABAPENTIN 158 158 17 13
SPIRONOLACTONE 146 146 18 47
CRESTOR 144 137 19 28
LOSARTAN POTASSIUM 133 132 20 15
TRAMADOL HCL 121 116 21 19
HYDROCHLOROTHIAZIDE 118 107 22 11
SERTRALINE HCL 115 93 23 23
ATORVASTATIN CALCIUM 112 105 24 12
METFORMIN HCL 109 101 25 9
DIGOXIN 107 107 26 40
ZOLPIDEM TARTRATE 104 83 27 20
TAMSULOSIN HCL 103 100 28 26
LANTUS 93 93 29 39
TRIAMTERENE-HYDROCHLOROTHIAZID 90 90 30 206
GLIPIZIDE 89 81 31 73
DOXAZOSIN MESYLATE 80 69 32 76
GLIMEPIRIDE 79 67 33 37
NAMENDA 78 78 34 31
DONEPEZIL HCL 75 75 35 25
CYMBALTA 74 74 36 45
SYMBICORT 70 68 37 183
LOSARTAN-HYDROCHLOROTHIAZIDE 70 57 37 44
PREDNISONE 69 57 39 36
TRAZODONE HCL 67 63 40 42
NOVOLOG 58 58 41 60
RAMIPRIL 56 56 42 104
ADVAIR DISKUS 55 55 43 61
MIRTAZAPINE 54 54 44 41
ACTOS 54 54 44 131
GEMFIBROZIL 52 52 46 93
LOVASTATIN 52 48 46 43
POLYETHYLENE GLYCOL 3350 51 51 48 49
FLUTICASONE PROPIONATE 50 48 49 32
FENTANYL 50 50 S2 49 64
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 30, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.